Category: Healthcare - Page 9

Insurance Formularies and Substitution: How Coverage Policies Affect Your Medication Costs

Insurance Formularies and Substitution: How Coverage Policies Affect Your Medication Costs

Insurance formularies control which drugs you can get and how much you pay. Learn how tiers, substitution rules, and prior authorization impact your medication access-and what you can do to protect yourself.

Read more
Current Drug Shortages: Which Medications Are Scarce Today in 2025

Current Drug Shortages: Which Medications Are Scarce Today in 2025

As of 2025, over 270 medications are in short supply in the U.S., including critical drugs like cisplatin, IV fluids, and ADHD treatments. Learn which drugs are hardest to find, why shortages keep happening, and how patients and providers are coping.

Read more
Medical Society Guidelines on Generic Drug Use: What Providers Really Think

Medical Society Guidelines on Generic Drug Use: What Providers Really Think

Medical societies have conflicting views on generic drug substitution. While most support generics for cost savings, neurologists and others warn against swapping NTI drugs like antiepileptics due to safety risks. Here’s what providers really think.

Read more
Survivorship Plans: What You Need to Know About Follow-Up, Screening, and Late Effects After Cancer

Survivorship Plans: What You Need to Know About Follow-Up, Screening, and Late Effects After Cancer

Survivorship care plans are essential after cancer treatment to guide follow-up visits, screen for late effects, and coordinate care between specialists. Learn what should be included and how to use your plan to stay healthy.

Read more
How to Verify Online News about Drug Recalls and Warnings

How to Verify Online News about Drug Recalls and Warnings

Learn how to spot fake drug recall alerts online and verify real ones using the FDA's official system. Stop panic, avoid dangerous mistakes, and protect your health with simple, step-by-step verification.

Read more
Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025

The FDA's 2025 guidance streamlines biosimilar approval by reducing the need for costly clinical trials, relying instead on advanced analytical data. This shift could cut costs, speed up access, and boost competition in the biologic drug market.

Read more
Liquid Biopsy: How Circulating Tumor DNA Is Changing Cancer Monitoring

Liquid Biopsy: How Circulating Tumor DNA Is Changing Cancer Monitoring

Liquid biopsy using circulating tumor DNA (ctDNA) is transforming cancer care by enabling non-invasive monitoring of tumor mutations, treatment response, and early recurrence. Learn how it works, where it excels, and why it's becoming standard in oncology.

Read more
Respiratory Infections and COVID-19: How Anticoagulants Interact with COVID Treatments and What It Means for Your Safety

Respiratory Infections and COVID-19: How Anticoagulants Interact with COVID Treatments and What It Means for Your Safety

COVID-19 can dangerously interact with blood thinners like warfarin and DOACs, increasing bleeding or clotting risks. Learn how Paxlovid affects anticoagulants, what to do if you're on one, and how to stay safe during infection.

Read more
How to Recognize Labeling Errors and Ask for Corrections in Machine Learning Datasets

How to Recognize Labeling Errors and Ask for Corrections in Machine Learning Datasets

Learn how to spot and fix labeling errors in machine learning datasets-especially in healthcare-using tools like cleanlab and Argilla. Reduce model errors and improve accuracy with practical correction workflows.

Read more
Hatch-Waxman Amendments: How Landmark Law Made Generic Drugs Possible

Hatch-Waxman Amendments: How Landmark Law Made Generic Drugs Possible

The Hatch-Waxman Act of 1984 created the modern system for generic drugs in the U.S., cutting approval costs by 90% and making life-saving medications affordable. It balanced innovation with access-and changed health care forever.

Read more